Brian Mueller
CIK: 0001514980
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BIOMARIN PHARMACEUTICAL INC
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Mar 17, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Tax Payment(F)Direct2.1K shares at avg. $56.05$119K - Mar 16, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct18.7K shares- - Mar 13, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Tax Payment(F)Direct9.9K shares at avg. $58.51$582K - Feb 25, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct6.7K shares- - Feb 25, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct7.2K shares- - Feb 25, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct2.6K shares- - Apr 30, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct375 shares at avg. $54.14$20K - Mar 17, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct16.6K shares- - Mar 14, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Tax Payment(F)Direct18.5K shares at avg. $69.44$1.3M - Feb 25, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct11K shares- - Feb 25, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct9.4K shares- - Feb 25, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct9.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 17, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | Tax Payment(F) | 2,117 | $56.05 | $118,658 | Direct |
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 18,740 | - | $0 | Direct |
| Mar 13, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | Tax Payment(F) | 9,945 | $58.51 | $581,882 | Direct |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 6,683 | - | $0 | Direct |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 7,230 | - | $0 | Direct |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 2,569 | - | $0 | Direct |
| Apr 30, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 375 | $54.14 | $20,301 | Direct |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 16,640 | - | - | Direct |
| Mar 14, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Tax Payment(F) | 18,497 | $69.44 | $1,284,432 | Direct |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 11,040 | - | - | Direct |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 9,367 | - | - | Direct |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 9,660 | - | - | Direct |
1-12 of 12 transactions
About Mueller Brian
Mueller Brian (SEC CIK 0001514980) files insider reports with the SEC as EVP, Chief Financial Officer of BIOMARIN PHARMACEUTICAL INC (BMRN).
Signal8 holds 6 ownership filings by Mueller Brian (5 Form 4, 1 Form 5), filed between Feb 27, 2025 and Mar 19, 2026. Those filings report 12 transactions, from Feb 25, 2025 to Mar 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mueller Brian's filings is in SAN RAFAEL, CA.
Recent filings by Mueller Brian
- Mar 17, 2026: Tax withholding of BMRN shares (Form 4, code F).
- Mar 16, 2026: Grant or award of BMRN shares (Form 4, code A).
- Mar 13, 2026: Tax withholding of BMRN shares (Form 4, code F).
- Feb 25, 2026: Grants or awards of BMRN shares (3 lines, Form 4, code A).
- Apr 30, 2025: Grant or award of BMRN shares (Form 5, code A).
Other insiders filing for BIOMARIN PHARMACEUTICAL INC (BMRN)
- Friberg Gregory R, EVP, Chief R&D Officer
- Plenge Robert M, Director
- Davis George Eric, EVP, Chief Legal Officer
- Countouriotis Athena, Director
- Walbert Timothy P, Director
- Ho Maykin, Director